![]() ![]() Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group and Verteporfin in Photodynamic Therapy (VIP) Study Group, Blinder KJ, Bradley S, Bressler NM, Bressler SB, Donato G, Hao Y, Ma C, Menchini U, Miller JW, Potter MJ, Pournaras C, Reaves A, Rosenfeld P, Strong HA, Stur M, Su XY Effect of Lesion Size, Visual Acuity, and Lesions Composition on Visual Acuity Change With and Without Verteporfin Therapy for Choroidal Neovascularization Secondary to Age-Related Macular Degeneration: TAP and VIP Report #1.Eyetech Study Group, Anti-vascular Endothelial Growth Factor Therapy for Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration: Phase II Study Results. ![]()
0 Comments
Leave a Reply. |